Commercial Physical & Biological Research Industry - SEC Form 4 Insider Trading Screener

Services Sector - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
100 results. Finviz
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company Name

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2024-03-14
MEDPMedpace Holdings, Inc.Keating Ashley M.DirS - Sale+OE$409.87-250250-50%-$102,468
2024-03-08
CRLCharles River Laboratories International, Inc.Knell Michael GunnarCSVP, Chief Accounting OfficerS - Sale$267.52-8087,024-10%-$216,156
M
2024-03-06
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$411.61-200,0005,539,662-3%-$82,321,250
M
2024-03-06
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$411.61-200,0004,733,019-4%-$82,321,250
D
2024-03-07
MEDPMedpace Holdings, Inc.Keating Ashley M.DirS - Sale+OE$415.00-4720-100%-$195,880
D
2024-03-04
MEDPMedpace Holdings, Inc.Geiger Jesse JPresS - Sale+OE$403.03-22,32121,503-51%-$8,996,033
M
2024-03-04
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$402.91-100,0005,739,662-2%-$40,291,000
M
2024-03-04
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$402.91-100,0004,933,019-2%-$40,291,000
2024-03-01
ABSIAbsci CorpRedmile Group, LLCDirP - Purchase$4.50+222,2228,253,316+3%+$999,999
2024-03-04
CRLCharles River Laboratories International, Inc.Knell Michael GunnarCSVP, Chief Accounting OfficerS - Sale$261.05-2,7507,832-26%-$717,890
2024-03-01
NRCNational Research CorpCommon Property Trust10%S - Sale$40.54-598,6533,854,284-13%-$24,269,393
D
2024-03-01
IQVIqvia Holdings Inc.Bousbib AriSee RemarksS - Sale+OE$250.53-31,6781,328,885-2%-$7,936,193
2024-02-29
IQVIqvia Holdings Inc.Staub W RichardSee RemarksS - Sale$247.80-14,10015,945-47%-$3,494,034
M
2024-02-29
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$400.25-100,0005,033,019-2%-$40,024,600
M
2024-02-29
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$400.25-100,0005,839,662-2%-$40,024,600
2024-02-29
CRLCharles River Laboratories International, Inc.Parisotto Shannon MCEVP, Disc, Safety AssessmentS - Sale$253.45-3,78633,686-10%-$959,545
2024-02-29
CRLCharles River Laboratories International, Inc.Creamer Victoria LEVP, Chief People OfficerS - Sale$253.70-5,00013,550-27%-$1,268,500
D
2024-02-28
IQVIqvia Holdings Inc.Knightly Kevin CSee RemarksS - Sale+OE$250.17-8,607652-93%-$2,153,176
M
2024-02-29
MEDPMedpace Holdings, Inc.Ewald Stephen PGC, Corp. Secy.S - Sale$395.19-1,51313,341-10%-$597,923
2024-02-29
MEDPMedpace Holdings, Inc.Geiger Jesse JPresS - Sale$393.51-2,5583,824-40%-$1,006,586
D
2024-02-28
MEDPMedpace Holdings, Inc.Keating Ashley M.DirS - Sale+OE$405.00-5000-100%-$202,500
M
2024-02-27
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$403.01-100,0005,133,019-2%-$40,300,500
M
2024-02-23
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$401.07-156,9286,039,662-3%-$62,938,689
M
2024-02-23
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$401.07-156,9285,233,019-3%-$62,938,689
2024-02-22
CRLCharles River Laboratories International, Inc.Barbo William DCorporate EVP, CCOS - Sale$248.50-4,05026,914-13%-$1,006,425
M
2024-02-21
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$392.66-136,0125,389,947-2%-$53,406,441
M
2024-02-21
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$392.66-136,0126,196,590-2%-$53,406,441
2024-02-16
IQVIqvia Holdings Inc.Sherbet EricSee RemarksS - Sale$241.50-1,00020,836-5%-$241,500
D
2024-02-16
IQVIqvia Holdings Inc.Knightly Kevin CSee RemarksS - Sale+OE$241.10-13,468652-95%-$3,247,165
M
2024-02-16
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$390.58-63,9885,525,959-1%-$24,992,323
M
2024-02-16
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$390.58-63,9886,332,602-1%-$24,992,323
D
2024-02-15
CRLCharles River Laboratories International, Inc.Parisotto Shannon MCEVP, Disc, Safety AssessmentS - Sale+OE$241.21-5,88237,884-13%-$1,418,767
2024-02-15
CRLCharles River Laboratories International, Inc.Laplume Joseph WEVP, Corp Strategy, DevelopS - Sale$238.93-83824,620-3%-$200,223
2024-02-06
FOXOFoxo Technologies Inc.Ward Martin ChristopherInterim CFO, 10%S - Sale$0.42-250,0001,300,000-16%-$105,000
2024-02-06
FOXOFoxo Technologies Inc.White Mark BrianInterim CEO, 10%S - Sale$0.42-250,0001,300,000-16%-$105,000
D
2024-01-26
MXCTMaxcyte, Inc.Johnston John JosephDirS - Sale+OE$5.12-5,000120,583-4%-$25,585
2019-06-07
NOTVInotiv, Inc.Leasure Robert Jr.Pres, CEOP - Purchase$1.98+7,500146,434+5%+$14,864
M
2024-01-04
NRCNational Research CorpAmandla Mk Trust10%S - Sale$40.85-7,2144,755,3170%-$294,710
2024-01-03
NRCNational Research CorpCommon Property Trust10%S - Sale$41.53-364,6254,452,937-8%-$15,142,876
2024-01-03
INCYIncyte CorpStein Steven HEVP, Chief Medical OfficerS - Sale$65.51-7,36590,218-8%-$482,481
M
2024-01-02
NRCNational Research CorpAmandla Mk Trust10%S - Sale$40.86-321,2394,762,531-6%-$13,125,005
2024-01-02
INCYIncyte CorpIyengar Vijay KEVP, GMAPPSS - Sale$65.00-65743,412-1%-$42,705
D
2023-12-26
MXCTMaxcyte, Inc.Johnston John JosephDirS - Sale+OE$4.53-5,000120,583-4%-$22,650
2023-12-21
RNGERange Impact, Inc.Cavanaugh Michael R.CEOP - Purchase$0.15+1,000,0001,879,791+114%+$150,000
2023-12-21
RNGERange Impact, Inc.Feighan Edward FDirP - Purchase$0.15+666,6673,690,917+22%+$100,000
M
2023-12-14
MEDPMedpace Holdings, Inc.Burwig Susan EEVP, OperationsS - Sale$303.96-12,40015,283-45%-$3,769,150
D
2023-12-14
CRLCharles River Laboratories International, Inc.Creamer Victoria LEVP, Chief People OfficerS - Sale+OE$225.00-5,52616,506-25%-$1,243,350
D
2023-12-14
NOTVInotiv, Inc.Garrett MichaelChief Commercial OfficerP - Purchase$2.83+5,00016,467+44%+$14,145
D
2023-12-14
NOTVInotiv, Inc.Beattie John GregoryCOOP - Purchase$3.12+47,966111,761+75%+$149,836
M
2023-12-12
MLCTRange Impact, Inc.Loconti Joseph E.10%P - Purchase$0.16+106,78320,827,180+1%+$17,080
M
2023-12-12
NRCNational Research CorpAmandla Mk Trust10%S - Sale$41.55-26,2635,083,770-1%-$1,091,264
M
2023-12-12
INCYIncyte CorpTray ThomasPrincipal Accounting OfficerS - Sale$61.55-1,27723,436-5%-$78,594
2023-12-12
OABIOmniab, Inc.Foehr Matthew WCEOP - Purchase$5.05+200,0002,645,442+8%+$1,010,000
M
2023-12-07
NRCNational Research CorpAmandla Mk Trust10%S - Sale$41.55-54,7045,110,033-1%-$2,273,206
M
2023-12-04
NRCNational Research CorpAmandla Mk Trust10%S - Sale$41.60-2,5505,164,7370%-$106,080
DM
2023-12-04
MXCTMaxcyte, Inc.Doerfler DouglasPres, CEOS - Sale+OE$5.14-124,450333,197-27%-$639,405
D
2023-12-01
IQVIqvia Holdings Inc.Knightly Kevin CSee RemarksS - Sale+OE$214.03-13,1171,973-87%-$2,807,472
DM
2023-11-29
MXCTMaxcyte, Inc.Doerfler DouglasPres, CEOS - Sale+OE$5.00-25,550333,197-7%-$127,750
M
2023-11-29
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$272.86-53,1676,396,590-1%-$14,507,101
M
2023-11-29
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$272.86-53,1675,589,947-1%-$14,507,101
2023-11-30
CRLCharles River Laboratories International, Inc.Laplume Joseph WEVP, Corp Strategy, DevelopS - Sale$197.73-1,85023,133-7%-$365,801
D
2023-11-27
MXCTMaxcyte, Inc.Johnston John JosephDirS - Sale+OE$4.59-5,000120,583-4%-$22,950
M
2023-11-27
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$274.96-46,8335,643,114-1%-$12,877,319
M
2023-11-27
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$274.96-46,8336,449,757-1%-$12,877,319
2023-11-22
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$277.81-25,0006,496,5900%-$6,945,250
2023-11-22
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$277.81-25,0005,689,9470%-$6,945,250
M
2023-11-20
NRCNational Research CorpAmandla Mk Trust10%S - Sale$42.07-7845,167,2870%-$32,987
2023-11-21
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$277.37-25,0005,714,9470%-$6,934,250
2023-11-21
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$277.37-25,0006,521,5900%-$6,934,250
2023-11-20
CRLCharles River Laboratories International, Inc.Girshick BirgitCorporate EVP, COOP - Purchase$187.82+1,32244,449+3%+$248,298
M
2023-11-17
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$274.68-100,0006,546,590-2%-$27,468,000
2023-11-15
NRCNational Research CorpAmandla Mk Trust10%S - Sale$42.10-4035,168,0710%-$16,968
D
2023-11-14
MXCTMaxcyte, Inc.Johnston John JosephDirS - Sale+OE$3.71-10,000120,583-8%-$37,100
M
2023-11-14
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$282.91-75,0006,646,590-1%-$21,217,980
M
2023-11-14
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$282.91-75,0005,839,947-1%-$21,217,980
2023-11-14
CRLCharles River Laboratories International, Inc.Foster James CCOB, Pres, CEOP - Purchase$178.05+5,620251,311+2%+$1,000,641
D
2023-11-09
CRLCharles River Laboratories International, Inc.Laplume Joseph WEVP, Corp Strategy, DevelopS - Sale+OE$173.48-9,12824,983-27%-$1,583,522
2023-11-10
OABIOmniab, Inc.Foehr Matthew WPres, CEOP - Purchase$4.27+95,0002,427,919+4%+$405,517
AD
2023-10-30
MLCTMalachite Innovations, Inc.Indemnity National Insurance Co10%P - Purchase$0.00+1,333,33321,333,333+7%+$0
D
2023-10-30
MLCTMalachite Innovations, Inc.Loconti Joseph E.10%P - Purchase$0.00+666,66720,720,397+3%+$0
2023-10-11
NRCNational Research CorpAmandla Mk Trust10%S - Sale$44.91-1,6015,168,4740%-$71,907
M
2023-03-02
SLGCSomalogic, Inc.Taich AdamInterim CEOS - Sale$2.34-22,996238,643-9%-$53,898
D
2023-09-15
SLGCSomalogic, Inc.Roelke Alison MarieChief People OfficerS - Sale+OE$2.33-3,4346,068-36%-$8,001
M
2023-03-02
SLGCSomalogic, Inc.Gutierrez RubenGCS - Sale$2.35-9,976110,534-8%-$23,416
M
2023-09-20
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$250.05-127,3086,721,590-2%-$31,833,495
M
2023-09-20
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$250.05-127,3085,914,947-2%-$31,833,495
D
2023-09-19
IQVIqvia Holdings Inc.Panagos ConstantinosSee RemarksS - Sale+OE$208.67-27,31714,250-66%-$5,700,340
M
2023-09-18
MEDPMedpace Holdings, Inc.Medpace Investors, LLC10%S - Sale$263.89-190,7646,042,255-3%-$50,339,894
M
2023-09-18
MEDPMedpace Holdings, Inc.Troendle August J.CEO, 10%S - Sale$263.89-190,7646,848,898-3%-$50,339,894
2023-09-14
ISPCIspecimen Inc.Bielak BenjaminChief Info Officer, SecretaryP - Purchase$0.72+18,00084,348+27%+$12,960
2023-09-01
INCYIncyte CorpSwain Paula JEVP, HRS - Sale$65.13-8,44977,530-10%-$550,283
DM
2023-08-28
MXCTMaxcyte, Inc.Johnston John JosephDirS - Sale+OE$3.70-5,000120,583-4%-$18,500
2023-08-24
CRLCharles River Laboratories International, Inc.Wallman Richard FDirP - Purchase$198.79+1,00023,528+4%+$198,786
2023-08-24
MLCTMalachite Innovations, Inc.Indemnity National Insurance Co10%P - Purchase$0.15+6,666,66733,333,333+25%+$1,000,000
D
2023-08-14
MEDPMedpace Holdings, Inc.Kraft Robert O.DirS - Sale+OE$265.67-13,782188-99%-$3,661,464
D
2023-08-14
OABIOmniab, Inc.Foehr Matthew WPres, CEOP - Purchase$5.48+45,0002,332,919+2%+$246,600
D
2023-08-10
CRLCharles River Laboratories International, Inc.Barbo William DCorporate EVP, CCOS - Sale+OE$217.24-5,76328,737-17%-$1,251,954
D
2023-08-10
CRLCharles River Laboratories International, Inc.Knell Michael GunnarCSVP, Chief Accounting OfficerS - Sale+OE$216.54-1,4719,940-13%-$318,530
2023-08-10
CRLCharles River Laboratories International, Inc.Laplume Joseph WEVP, Corp Strategy, DevelopS - Sale$216.52-70024,983-3%-$151,564
2023-08-01
INCYIncyte CorpStein Steven HEVP, Chief Medical OfficerS - Sale$63.28-21,51197,583-18%-$1,361,216

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top